Results 251 to 260 of about 612,549 (305)

Lactylation‐Driven YTHDC1 Alleviates MASLD by Suppressing PTPN22‐Mediated Dephosphorylation of NLRP3

Advanced Science, EarlyView.
In MASLD, YTHDC1 undergoes increased lactylation and ubiquitination, reducing its expression. AARS1 mediates lactylation at lysine 565, while disrupted binding to LDHA further promotes lactylation, suppressing YTHDC1. This downregulation enhances PTPN22 mRNA stability, leading to NLRP3 dephosphorylation and activation, which exacerbates inflammation ...
Feng Zhang, Linghua Zeng, Kunkun Zou, Keying Lin, Fangting Yao, Jinglun Song, Shumeng Zhang, Hanshu Feng, Zhichao Yang, Chunlei Wang, Hongtao Diao, Xue Kong, Tengfei Pan, Joonki Kim, Tianqi Duo, Linqiang Li, Yu Bian   +16 more
wiley   +1 more source

PRMT1-Mediated PARP1 Methylation Drives Lung Metastasis and Chemoresistance via P65 Activation in Triple-Negative Breast Cancer. [PDF]

Research (Wash D C)
Zhang J, Huang Z, Song C, Wu S, Xie J, Zou Y, Xie X, Wu T, Yang H, Tang H.   +9 more
europepmc   +1 more source

A Case of Cavitary Lung Metastasis From Prostate Cancer. [PDF]

Respirol Case Rep
Ohnaka S, Aoyama M, Arai R, Hattori S, Kubo Y, Suzuki S, Yoshimura T, Ebihara A, Morikawa T, Shigemitsu H, Kuwahira I.   +10 more
europepmc   +1 more source

A Decade-long Battle: Successful Stereotactic Radiotherapy for a Delayed Lung Metastasis from Endometrial Cancer. [PDF]

Gynecol Minim Invasive Ther
Hama Y, Tate E.
europepmc   +1 more source

Impact of cancer-directed surgery for gastric cancer patients with lung metastasis: a prognosis analysis. [PDF]

J Gastrointest Oncol
Tan Z, Du X, Zeng M, Huang Y, Cai Y, Huang S.   +5 more
europepmc   +1 more source

Lipid nanoparticle-delivered IFNα2 activates Cxcl9 to increase T cell tumor recruitment to suppress lung metastasis. [PDF]

J Immunother Cancer
Fick K, Kerns N, Zhao Y, Tiamiyu Z, Poschel D, Czabala P, Yang D, Tang Y, Xie J, Fesenkova V, Pacholczyk R, Shi H, Liu K, Redd PS.   +13 more
europepmc   +1 more source

ZWINT down-regulated by miR-495-3p inhibited lung metastasis of breast cancer by blocking p38 MAPK signaling pathway activation. [PDF]

Hum Cell
Shao MT, Li WW, Li Y, Chen P, Yu SS, Lu WJ, Chen CM, Dong Y, Zhang YW, Zhang QC.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Modeling Ewing Sarcoma Lung Metastasis

Current Protocols, 2023
AbstractEwing Sarcoma (EwS) is the second most common malignant bone tumor in adolescents and young adults. The single‐most powerful predictor of outcome in EwS is presence of metastatic burden at the time of diagnosis. Patients with metastatic Ewing Sarcoma have an abysmal 5‐year survival rate of 10%‐25%, which has not changed over the past 30‐40 ...
Dasgupta, Atreyi, Kurenbekova, Lyazat, Patel, Tajhal D, Rajapakshe, Kimal, Ghosal, Gargi, Nirala, Bikesh, Coarfa, Cristian, Yustein, Jason   +7 more
openaire   +3 more sources

Lung metastasis of a meningioma

Neuroradiology, 1983
Case report of a 35-year-old male patient. 1976: operation for a falx-meningioma. 1981: meningioma recurrence and further intracranial meningiomas.1976 and 1981 endotheliomatous meningioma: no signs of malignancy. Prior to the 2nd operation in 1981 a lung tumor was diagnosed for the first time.
S, Wende, J, Bohl, R, Schubert, V, Schulz   +3 more
openaire   +2 more sources

Splenic metastasis from lung cancer

The Netherlands Journal of Medicine, 1995
Splenic metastasis from lung cancer is a rare clinical event, most often diagnosed at the time of autopsy. We report 2 cases of splenic metastasis with a primary lung cancer. The first case was a 76-year-old man presenting with a recurrent solitary splenic metastasis 14 months after surgical removal of a squamous cell carcinoma of the lung.
A, Kinoshita, M, Nakano, M, Fukuda, T, Kasai, N, Suyama, K, Inoue, T, Nakata, K, Shigematsu, M, Oka, K, Hara   +9 more
openaire   +2 more sources